돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 562559생성일: 2026년 10월 26일

Imatinib → Imatinib Mesylate

https://huagongshe.com/reaction/562559

반응식

참여 물질

역할이름HCID투입량
반응물ImatinibHCID 5291—
반응물Methanesulfonic AcidHCID 6395—
반응물1-MethoxyethanolHCID 3015637—
반응물1-EthoxyethanolHCID 10129898—
용매MethanolHCID 887—
용매AcetonitrileHCID 6342—
용매NitromethaneHCID 6375—
용매Propylene CarbonateHCID 7924—
용매N-methyl-2-pyrrolidoneHCID 13387—
생성물Imatinib MesylateHCID 123596—

반응 단계

Alternatively, the solution may be prepared by admixing imatinib base, methanesulfonic acid and a solvent selected from the group consisting of: methanol, methoxyethanol or ethoxyethanol, N-methylpyrrolidone, propylene carbonate, acetonitrile, nitromethane to obtain a mixture; and heating the mixture to obtain an imatinib mesylate solution. Heating the mixture to obtain an imatinib mesylate solution is preferably to a temperature of about 20° C. to about 85° C., more preferably of about 60° C. to about 80° C. Preferably, the obtained solution is further cooled to a temperature of about 20° C. to about 0° C. prior to the addition of the anti-solvent. Preferably the solution of imatinib mesylate is gradually added to the anti-solvent under stirring. Preferably, the solution of imatinib mesylate is added to an excess of anti-solvent.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08067421B2
출처 데이터셋uspto-grants-2011_11
ORD IDord-c47d0b859c424b8288f13b2b12baf475
출처 메모uspto-grants-2011_11